Nitin Kataria: Rethinking Embryo Grading in Modern IVF Practice
Nitin Kataria, Senior Clinical Embryologist and Quality Manager at Indira IVF Group, shared a post on LinkedIn:
“Embryo grading: beyond numbers, towards understanding potential
As embryologists, we often find ourselves translating microscopic observations into meaningful clinical decisions. Embryo grading is one such critical step—where science meets judgment. Traditionally, embryo grading has been based on morphological assessment:
- Cleavage-stage embryos: symmetry, fragmentation, blastomere number
- Blastocysts: expansion, inner cell mass (ICM), and trophectoderm (TE) quality
While these grading systems provide a standardized framework, it’s important to remember:
- A ‘perfect-looking’ embryo is not always euploid
- A ‘poor-grade’ embryo can still result in a healthy live birth
So what does grading truly represent?
It reflects ‘developmental competence at a given time point’, not absolute viability.
In modern IVF practice, embryo selection is evolving:
- Time-lapse imaging offers dynamic developmental insights
- Genetic testing (PGT-A) adds a chromosomal dimension
- Clinical context – maternal age, history, endometrial receptivity – remains crucial
As senior embryologists, our role is not just to grade embryos, but to:
- Interpret morphology in context
- Communicate realistic expectations to clinicians and patients
- Continuously adapt to emerging technologies
Embryo grading is not a verdict – it’s a guide.
And like all guides, it works best when combined with experience, data, and clinical judgment.”

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic
